Literature DB >> 22466945

Carboxymethylpachymaran enhances immunologic function of dendritic cells cultured in two kinds of hepatoma carcinoma cell line's supernatant via nuclear factor κ B/Rel pathway.

Zhuo Chen1, Bin Yu, Xian-Lin Wu, Cong-Qi Dai, Guo-Qiang Qian, Jian-Zhong Yu, Hai-Bin He, Zhi-Xin Wang, Jun Hou, Xiao-Yin Chen.   

Abstract

OBJECTIVE: To study the immunologic function of dendritic cells (DCs) cultured in two kinds of hepatoma cell line's supernatant and the enhancing effects of carboxymethylpachymaran (CMP) on DCs.
METHODS: DCs were harvested after stimulation by granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-4 from umbilical cord blood using density-gradient centrifugation method. Cultured supernatant of two hepatoma cell lines (HepG2 and HepG2.2.15) were collected for condition medium (CM) according to a volume ratio of supernatant to incomplete RPMI-1640 medium, which was 3:1. CMP was dissolved in incomplete RPMI-1640 medium. Experimental groups were divided according to the culture medium, either CM or with CMP in it. DCs subsets CD83, CD86, CD1a, and d-related human leukocyte antigens (HLA-DR) were analyzed by flow cytometry. The proliferation ability of allogeneic T cells in mixed lymphocyte reaction (MLR) stimulated by DCs was examined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) analysis. IL-12p70, interferon-γ (IFN-γ), and nuclear factor κB (NF-κB) were detected by enzyme-linked immunosorbent assay analysis.
RESULTS: The proliferation of lymphocytes and secreting level of IL-12 and expression of phenotype of DCs cultured in two kinds of CM were lower than those of normal group (P <0.01). Compared with the normal group, groups treated with CMP showed a higher expression level of DCs subsets, lymphocyte reproductive activity, as well as IL-12 and IFN-γ secretion levels. Groups treated with CMP also demonstrated higher levels of DCs phenotype expression and IL-12 and IFN-γ secretion in supernatant of MLR and higher lymphocyte reproductive activity compared with CM group (P <0.05). Compared with the normal group, the expression level of NF-κB in DCs nuclear was higher in CMP groups but lower in two CM groups (P <0.05). After CMP was added, the NF-κB expression levels of two CM groups were increased compared with levels before CMP was added (P <0.05). However, there was no significant difference between the two CM groups (P >0.05).
CONCLUSIONS: Two kinds of hepatoma cell line's supernatant can inhibit the immunologic function of DCs. This suppressive effect may be related to the inhibition of NF-κB/Rel pathway. CMP may up-regulate the DCs function by activating the NF-κB/Rel pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22466945     DOI: 10.1007/s11655-011-0943-4

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  17 in total

Review 1.  Tolerogenic dendritic cells.

Authors:  Ralph M Steinman; Daniel Hawiger; Michel C Nussenzweig
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

Review 2.  A fresh look at tumor immunosurveillance and immunotherapy.

Authors:  M J Smyth; D I Godfrey; J A Trapani
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

3.  Effects of heat shock protein gp96 on human dendritic cell maturation and CTL expansion.

Authors:  Yuxia Zhang; Yanlu Zan; Ming Shan; Changmei Liu; Ming Shi; Wei Li; Zhixin Zhang; Na Liu; Fusheng Wang; Weidong Zhong; Fulian Liao; George F Gao; Po Tien
Journal:  Biochem Biophys Res Commun       Date:  2006-04-05       Impact factor: 3.575

4.  [Phenotype and function of myeloid dendritic cells pulsed with hepatitis B virus antigens in patients with HBV-associated hepatocellular carcinoma].

Authors:  Shen Qian; Ming Shi; Hui Zhang; Bing Zhang; Dong-ping Xu; Fu-sheng Wang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2005-01-26

5.  Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization.

Authors:  Shuang-Jian Qiu; Lina Lu; Chunping Qiao; LiangFu Wang; Zhong Wang; Xiao Xiao; Shiguang Qian; John J Fung; Sheng-Long Ye; C Andrew Bonham
Journal:  J Cancer Res Clin Oncol       Date:  2005-04-08       Impact factor: 4.553

6.  Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection.

Authors:  S Kakumu; S Ito; T Ishikawa; Y Mita; T Tagaya; Y Fukuzawa; K Yoshioka
Journal:  J Gastroenterol Hepatol       Date:  2000-04       Impact factor: 4.029

Review 7.  How tumors escape immune destruction and what we can do about it.

Authors:  E Gilboa
Journal:  Cancer Immunol Immunother       Date:  1999-10       Impact factor: 6.968

Review 8.  Recent advances in the study of dendritic cells and follicular dendritic cells.

Authors:  C Caux; Y J Liu; J Banchereau
Journal:  Immunol Today       Date:  1995-01

Review 9.  Tumor immunity meets autoimmunity: antigen levels and dendritic cell maturation.

Authors:  Michael T Spiotto; Yang-Xin Fu; Hans Schreiber
Journal:  Curr Opin Immunol       Date:  2003-12       Impact factor: 7.486

10.  Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells.

Authors:  Ping Yu; Michael T Spiotto; Youjin Lee; Hans Schreiber; Yang-Xin Fu
Journal:  J Exp Med       Date:  2003-04-14       Impact factor: 14.307

View more
  1 in total

1.  Andrographolide as an anti-H1N1 drug and the mechanism related to retinoic acid-inducible gene-I-like receptors signaling pathway.

Authors:  Bin Yu; Cong-qi Dai; Zhen-you Jiang; En-qing Li; Chen Chen; Xian-lin Wu; Jia Chen; Qian Liu; Chang-lin Zhao; Jin-xiong He; Da-hong Ju; Xiao-yin Chen
Journal:  Chin J Integr Med       Date:  2014-06-28       Impact factor: 1.978

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.